|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | G01N 33/80 | |
| A61K 38/17 | |||
| G01N 33/90 | |||
| C07K 14/72 | |||
| G01N 33/72 | |||
| A61P 7/06 |
| (11) | Number of the document | 2303918 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09770573.5 |
| Date of filing the European patent application | 2009-06-26 | |
| (97) | Date of publication of the European application | 2011-04-06 |
| (45) | Date of publication and mention of the grant of the patent | 2018-09-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2009/003843 |
| Date | 2009-06-26 |
| (87) | Number | WO 2009/158035 |
| Date | 2009-12-30 |
| (30) | Number | Date | Country code |
| 133354 P | 2008-06-26 | US |
| (72) |
SHERMAN, Matthew, L., US
BORGSTEIN, Niels, US
|
| (73) |
Acceleron Pharma, Inc.,
128 Sidney Street, Cambridge, MA 02139,
US
|
| (54) | SOLUBLE ACTRIIa AS ACTIVIN-ACTRIIA ANTAGONIST FOR USE IN TREATING ANEMIA |
| SOLUBLE ACTRIIa AS ACTIVIN-ACTRIIA ANTAGONIST FOR USE IN TREATING ANEMIA |